[
  {
    "slug": "dc-redundancy-cd4-priming",
    "title": "DC Redundancy Enables CD4+ T Cell Priming in PDAC",
    "venue": "Cancer Cell",
    "year": "2026",
    "date": "2026-07-13",
    "tags": ["PDAC", "cDC2", "CD4+ T cells", "IFNγ", "STING agonist", "immunotherapy"],
    "excerpt": "cDC2-CD4+ T 细胞-IFNγ 轴可独立于 CD8+ T 细胞/MHC-I 清除免疫原性差的 PDAC，三联疗法 (STING + anti-PD-1 + anti-CTLA-4) 实现持久缓解。"
  }
]